Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy
出版年份 2016 全文链接
标题
Clinical, Pathological, and Molecular Characterization of Infant Medulloblastomas Treated with Sequential High-Dose Chemotherapy
作者
关键词
-
出版物
PEDIATRIC BLOOD & CANCER
Volume 63, Issue 9, Pages 1527-1534
出版商
Wiley
发表日期
2016-05-05
DOI
10.1002/pbc.26042
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Pilot Study of Intensive Chemotherapy With Peripheral Hematopoietic Cell Support for Children Less Than 3 Years of Age With Malignant Brain Tumors, the CCG-99703 Phase I/II Study. A Report From the Children's Oncology Group
- (2015) Bruce H. Cohen et al. PEDIATRIC NEUROLOGY
- Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohort
- (2014) Torsten Pietsch et al. ACTA NEUROPATHOLOGICA
- Tumor-Associated Macrophages in SHH Subgroup of Medulloblastomas
- (2014) A. S. Margol et al. CLINICAL CANCER RESEARCH
- Postponed Is Not Canceled: Role of Craniospinal Radiation Therapy in the Management of Recurrent Infant Medulloblastoma—An Experience From the HIT-REZ 1997 & 2005 Studies
- (2014) Klaus Müller et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- High-dose busulfan-thiotepa with autologous stem cell transplantation followed by posterior fossa irradiation in young children with classical or incompletely resected medulloblastoma
- (2014) Guillaume Bergthold et al. PEDIATRIC BLOOD & CANCER
- Molecular sub-group-specific immunophenotypic changes are associated with outcome in recurrent posterior fossa ependymoma
- (2013) Lindsey M. Hoffman et al. ACTA NEUROPATHOLOGICA
- Proton Radiation Therapy for Pediatric Medulloblastoma and Supratentorial Primitive Neuroectodermal Tumors: Outcomes for Very Young Children Treated With Upfront Chemotherapy
- (2013) Rachel B. Jimenez et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Recurrence patterns across medulloblastoma subgroups: an integrated clinical and molecular analysis
- (2013) Vijay Ramaswamy et al. LANCET ONCOLOGY
- Induction Chemotherapy and Conformal Radiation Therapy for Very Young Children With Nonmetastatic Medulloblastoma: Children's Oncology Group Study P9934
- (2012) David M. Ashley et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular subgroups of medulloblastoma: the current consensus
- (2011) Michael D. Taylor et al. ACTA NEUROPATHOLOGICA
- Histology predicts a favorable outcome in young children with desmoplastic medulloblastoma
- (2011) Sarah E.S. Leary et al. CANCER
- Treatment of young children with localized medulloblastoma by chemotherapy alone: Results of the prospective, multicenter trial HIT 2000 confirming the prognostic impact of histology
- (2011) A. O. von Bueren et al. NEURO-ONCOLOGY
- Practical Grading System for Evaluating Cisplatin Ototoxicity in Children
- (2010) Kay W. Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Survival and Prognostic Factors of Early Childhood Medulloblastoma: An International Meta-Analysis
- (2010) Stefan Rutkowski et al. JOURNAL OF CLINICAL ONCOLOGY
- Medulloblastoma Comprises Four Distinct Molecular Variants
- (2010) Paul A. Northcott et al. JOURNAL OF CLINICAL ONCOLOGY
- Neuropsychological functioning of children treated with intensive chemotherapy followed by myeloablative consolidation chemotherapy and autologous hematopoietic cell rescue for newly diagnosed CNS tumors: An analysis of the Head Start II survivors
- (2010) Stephen A. Sands et al. PEDIATRIC BLOOD & CANCER
- Current Treatment Approaches for Infants with Malignant Central Nervous System Tumors
- (2009) L. Lafay-Cousin et al. ONCOLOGIST
- M1 Medulloblastoma: high risk at any age
- (2008) Robert P. Sanders et al. JOURNAL OF NEURO-ONCOLOGY
- Outcome of children less than three years old at diagnosis with non-metastatic medulloblastoma treated with chemotherapy on the “Head Start” I and II protocols
- (2008) Girish Dhall et al. PEDIATRIC BLOOD & CANCER
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now